The role of the microbiome in NAFLD and NASH
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of cardiometabolic syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly becoming the most prevalent liver disease worldwide. A sizable minority of NAFLD patients develop nonalcoholic steatohepatitis (NASH), which is characterized by inflammatory changes that can lead to progressive liver damage, cirrhosis, and hepatocellular carcinoma. Recent studies have shown that in addition to genetic predisposition and diet, the gut microbiota affects hepatic carbohydrate and lipid metabolism as well as influences the balance between pro‐inflammatory and anti‐inflammatory effectors in the liver, thereby impacting NAFLD and its progression to NASH. In this review, we will explore the impact of gut microbiota and microbiota‐derived compounds on the development and progression of NAFLD and NASH, and the unexplored factors related to potential microbiome contributions to this common liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of these TLRs can contribute to the development of NAFLD and nonalcoholic steatohepatitis (NASH), with the most extensively studied pathway being LPS-TLR4 signaling.180”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [180]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 2×
“However, conven-tionalization of germ-free mice with normal mouse microbiota induces de novo hepatic lipogenesis, in addition to increased body fat content and insulin resistance (Ba¨ckhed et al , 2004).”
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · cited 1×
“Under physiological conditions, tight junction proteins, such as zonula occludens, seal adjacent epithelial cells at the apical sites and prevent bacteria from entering the intestinal mucosa and the bloodstream (Turner, 2009).”
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“…in the digestion of food and facilitates the absorption of the dietary molecules into the portal and systemic circulation (Jumpertz et al , 2011; Ridaura et al , 2013), interacts with the mucosal immune system, to shape development of its antigen recognition, recruitment, proliferation, and…”
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241 · cited 3×
“In addition, SCFAs are also potent signaling molecules through binding to G-protein-coupled receptors GPR41, GPR43, and GPR109A (Samuel et al , 2008; Maslowski et al , 2009).”
Research works printed but not linked: 1
- Ackermann D, Schutze H (1910) The formation of trimethylamine by bacterium prodigiosum. Zentralb Physiol 24: 210–211
Cited by
Items 201–300 of 548
Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation
Dery, K. J., Górski, A., Międzybrodzki, R., Farmer, D. G., & Kupiec‐Weglinski, J. W. (2020) · Transplantation · doi:10.1097/tp.0000000000003565 · Cited by 28
Lipták, R., Gromová, B., & Gardlík, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.665520 · Cited by 30
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
Dongiovanni, P., Meroni, M., Longo, M., Fargion, S. R., & Fracanzani, A. L. (2021) · Biomedicines · doi:10.3390/biomedicines9111524 · Cited by 30
Pezzino, S., Sofia, M., Mazzone, C., Castorina, S., Puleo, S., Barchitta, M., Agodi, A., Gallo, L., Greca, G. L., & Latteri, S. (2023) · Biology · doi:10.3390/biology12050662 · Cited by 30
Okamoto, K., Koda, M., Okamoto, T., Onoyama, T., Miyoshi, K., Kishina, M., Matono, T., Kato, J., Tokunaga, S., Sugihara, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0219412 · Cited by 28
Physiopathologie des stéatoses hépatiques métaboliques
Anty, R., & Gual, P. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.09.051 · Cited by 33
Ji, X., Chen, M., Zhao, M., Song, Y., Lin, Y., Yin, H., & Zhao, L. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104333 · Cited by 27
Mazzini, F. N., Cook, F., Gounarides, J., Marciano, S., Haddad, L., Tamaroff, A. J., Casciato, P. C., Narvaez, A., Mascardi, M. F., Anders, M., et al. (2021) · Metabolomics · doi:10.1007/s11306-021-01810-6 · Cited by 27
Time‐limited diets and the gut microbiota in cardiometabolic disease
Ratiner, K., Shapiro, H., Goldenberg, K., & Elinav, E. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13288 · Cited by 27
Self-citationLatteri, S., Sofia, M., Puleo, S., Vincenzo, A. D., Cinti, S., & Castorina, S. (2023) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-023-02821-8 · Cited by 30
Vazquez-Uribe, R., Hedin, K. A., Licht, T. R., Nieuwdorp, M., & Sommer, M. O. A. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.04.021 · Cited by 28
Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer
Yeoh, B. S., Saha, P., Golonka, R. M., Zou, J., Petrick, J. L., Abokor, A. A., Xiao, X., Bovilla, V. R., Bretin, A., Rivera‐Esteban, J., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.08.033 · Cited by 26
Wang, Z., Zhou, S., & Jiang, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1067813 · Cited by 27
The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
Munteanu, C., & Schwartz, B. (2023) · Antioxidants · doi:10.3390/antiox12040903 · Cited by 30
Characterization of gut microbiota in adults with coronary atherosclerosis
Dong, Y., Xu, R., Chen, X., Yang, C., Jiang, F., Shen, Y., Li, Q., Fang, F., Li, Y., & Shen, X. (2023) · PeerJ · doi:10.7717/peerj.15245 · Cited by 28
Bacil, G. P., Romualdo, G. R., Rodrigues, J., & Barbisan, L. F. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113513 · Cited by 27
The Pan-liver Network Theory: From Traditional Chinese Medicine to Western Medicine
Zhang, Y., & Fang, X.-M. (2023) · The Chinese Journal of Physiology · doi:10.4103/cjop.cjop-d-22-00131 · Cited by 30
Perazza, F., Leoni, L., Selvatici, B., Girolami, F., Bonalumi, A., Beretta, A., Ferri, S., Petroni, M. L., Piscaglia, F., Ravaioli, F., et al. (2025) · Nutrients · doi:10.3390/nu17111906 · Cited by 26
Yu, X., Mi, S., Ye, J., & Lou, G. (2021) · Journal of Cancer · doi:10.7150/jca.64833 · Cited by 25
Guo, J., Xu, Y., Chen, L., Zhang, S.-X., Liou, Y., Chen, X., Tan, Z., Zhou, H., Zhang, W., & Chen, Y. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.10.004 · Cited by 25
Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery
Micó-Carnero, M., Rojano-Alfonso, C., Álvarez‐Mercado, A. I., Gracia‐Sancho, J., Casillas-Ramírez, A., & Peralta, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010044 · Cited by 26
Park, E., Jeong, J., Won, S., Sharma, S. P., Gebru, Y. A., Ganesan, R., Gupta, H., Suk, K. T., & Kim, D. J. (2021) · Cells · doi:10.3390/cells10102634 · Cited by 24
Riezu‐Boj, J. I., Barajas, M. A., Pérez, T., Pajares, M. J., Araña, M., Milagro, F. I., & Urtasun, R. (2022) · Nutrients · doi:10.3390/nu14245212 · Cited by 24
Lim, J. J., Diener, C., Wilson, J. G., Valenzuela, J. J., Baliga, N. S., & Gibbons, S. M. (2023) · Nature Communications · doi:10.1038/s41467-023-41424-1 · Cited by 25
Leca, B. M., Lagojda, L., Kite, C., Karteris, E., Kassi, E. N., Randeva, H. S., & Kyrou, I. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2365791 · Cited by 26
Ziółkiewicz, A., Niziński, P., Soja, J., Oniszczuk, T., Combrzyński, M., Kondracka, A., & Oniszczuk, A. (2024) · Metabolites · doi:10.3390/metabo14060346 · Cited by 27
Gil‐Gómez, A., Brescia, P., Rescigno, M., & Romero‐Gómez, M. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1723752 · Cited by 26
Tsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Biomedicines · doi:10.3390/biomedicines14010151 · Cited by 25
Asadullah, M., Shivashankar, R., Shalimar, S., Kandasamy, D., Kondal, D., Rautela, G., Peerzada, A., Grover, B., Amarchand, R., Nayak, B., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263768 · Cited by 25
Yu, S., Jiang, J., Li, Q., Liu, X., Wang, Z., Yang, L., & Ding, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.855008 · Cited by 24
TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo
Akcora, B. Ö., Dathathri, E., Ortiz‐Perez, A., Gabriël, A. V., Storm, G., Prakash, J., & Bansal, R. (2019) · The FASEB Journal · doi:10.1096/fj.201900215rr · Cited by 23
Abo, H., Muraki, A., Harusato, A., Imura, T., Suzuki, M., Takahashi, K., Denning, T. L., & Kawashima, H. (2023) · JCI Insight · doi:10.1172/jci.insight.165944 · Cited by 24
Identifying High-Risk NASH Patients: What We Know so Far
Schulz, M., & Tacke, F. (2020) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s265473 · Cited by 25
Min, R. W. M., Aung, F. W. M., Liu, B., Arya, A., & Win, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082035 · Cited by 24
Xue, Y., Wei, Y., Cao, L., Shi, M., Sheng, J., Xiao, Q., Cheng, Z., Luo, T., Jiao, Q., Wu, A., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116933 · Cited by 22
Non-alcoholic fatty liver disease: Dietary and nutraceutical approaches
Cogorno, L., Formisano, E., Vignati, A., Prigione, A., Tramacere, A., Borgarelli, C., Sukkar, S. G., & Pisciotta, L. (2023) · Liver Research · doi:10.1016/j.livres.2023.08.005 · Cited by 22
Zhang, Q.-J., Gong, J., Xiang, H., Hu, R., Yang, X., Lv, J., Zhang, W., Liu, M., Deng, X., Yuan, X., et al. (2023) · Animal nutrition · doi:10.1016/j.aninu.2023.05.015 · Cited by 22
Savari, F., & Mard, S. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28468 · Cited by 25
Gupta, M., Krishan, P., Kaur, A., Arora, S., Trehanpati, N., Singh, T. G., & Bedi, O. (2021) · Inflammation Research · doi:10.1007/s00011-021-01480-z · Cited by 23
The Role of Ophiopogonin D in Atherosclerosis: Impact on Lipid Metabolism and Gut Microbiota
Zhang, Y., Qu, S., Zhang, L., Gu, Y., Chen, Y., Huang, Z., Liu, M., Zou, W., Jiang, J., Chen, J., et al. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500683 · Cited by 22
Tawfiq, R. A., Nassar, N. N., Hammam, O. A., Allam, R. M., Elmazar, M. M., Abdallah, D. M., & Attia, Y. M. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109953 · Cited by 23
Sheng, X., Wang, L., Zhan, P., He, W., Tian, H., & Liu, J. (2023) · Foods · doi:10.3390/foods12163074 · Cited by 22
Circulating metabolite signatures indicate differential gut-liver crosstalk in lean and obese MASLD
Haag, M., Winter, S., Kemas, A. M., Tevini, J., Feldman, A., Eder, S. K., Felder, T. K., Datz, C., Paulweber, B., Liebisch, G., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.180943 · Cited by 22
Pierro, F. D., & Pane, M. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.12.025 · Cited by 21
Che, Z., Xue, W., Zhao, X., Hu, C., & Tian, Y. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000914 · Cited by 23
Han, C., Li, Z., Liu, R., Zhao, Z., Wang, Y., Zuo, X., Zhang, Y., Geng, Z., Huang, H., Pan, X., et al. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12854 · Cited by 21
Zhang, Z., Lu, W., Liu, P., Li, M., Ge, X., Yu, B., Wu, Z., Liu, G., Ding, N., Cui, B., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155068 · Cited by 20
Zhou, S., Huang, G., & Long, R. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.140200 · Cited by 20
Zhang, J., Zhou, J., He, Z., Xia, Z., Liu, H., Wu, Y., Chen, S., Wu, B.-M., & Li, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142276 · Cited by 29
Harada, N., Hanada, K., Minami, Y., Kitakaze, T., Ogata, Y., Tokumoto, H., Sato, T., Kato, S., Inui, H., & Yamaji, R. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00461.2019 · Cited by 22
Sun, Q., Xin, X., An, Z., Hu, Y., & Feng, Q. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854879 · Cited by 20
Khalil, A. A., Elsheashaey, A., Abdelsameea, E., Obada, M., Mohamed Bayomy, F. F., & El‐Said, H. (2022) · British Journal of Biomedical Science · doi:10.3389/bjbs.2021.10191 · Cited by 19
Meiring, S., van Baar, A. C. G., Sørensen, N., Holleman, F., Soeters, M. R., Nieuwdorp, M., & Bergman, J. J. G. H. M. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.856661 · Cited by 21
Preethy, S., Ikewaki, N., Levy, G. A., Raghavan, K., Dedeepiya, V. D., Yamamoto, N., Srinivasan, S., Ranganathan, N., Iwasaki, M., Senthilkumar, R., et al. (2022) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2022-000985 · Cited by 19
Wu, J., Qian, H., Zhou, Y., Xu, J., Zhang, Z., Chen, C., Wu, Y.-H., Chen, Y., Qin, L., & Li, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.211 · Cited by 20
Liu, S., Luorong, Q., Hu, K., Cao, W., Wei, T., Liu, H., & Zhang, D. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2106.06043 · Cited by 21
Gut Microbiota Host–Gene Interaction
Cuomo, P., Capparelli, R., Alifano, M., Iannelli, A., & Iannelli, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213717 · Cited by 21
Srikanth, Y., Dontiboina, H. R., Anusha, V. L., Dumala, N., Viswanadh, M. K., Chakravarthi, G., Nalluri, B. N., Yadagiri, G., & Ramakrishna, K. (2025) · Plants · doi:10.3390/plants14050827 · Cited by 21
Nakamura, S., Nakamura, K., Yokoi, Y., Shimizu, Y., Ohira, S., Hagiwara, M., Song, Z., Gan, L. H., Aizawa, T., Hashimoto, D., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-30997-y · Cited by 19
Marine algal polysaccharides as future potential constituents against non-alcoholic steatohepatitis
Lu, S., Tan, K., Zhong, S., & Cheong, K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126247 · Cited by 18
Olotu, T., & Ferrell, J. M. (2024) · Microorganisms · doi:10.3390/microorganisms12122488 · Cited by 18
NASH and the Gut Microbiome: Implications for New Therapies
Tsay, C. J., & Lim, J. K. (2022) · Clinical Liver Disease · doi:10.1002/cld.1170 · Cited by 20
Indole supplementation ameliorates MCD-induced NASH in mice
Zhu, B., Li, H., Lu, B., Guo, X., Wu, C., Wang, F., Li, Q., Xie, L., Glaser, S. S., Francis, H., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109041 · Cited by 18
Kong, C., Li, Z., Chen, H., Mao, Y., Han, B., Guo, J.-J., & Wang, L. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac181 · Cited by 19
Simas, A. M., Kramer, C. D., & Genco, C. A. (2022) · Frontiers in Oral Health · doi:10.3389/froh.2021.784448 · Cited by 18
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
Rodríguez‐Lara, A., Rueda‐Robles, A., Sáez‐Lara, M. J., Plaza‐Díaz, J., & Álvarez‐Mercado, A. I. (2023) · Pathogens · doi:10.3390/pathogens12070940 · Cited by 18
Gruzdev, S., Podoprigora, I. V., & Gizinger, O. A. (2024) · Archives of Microbiology · doi:10.1007/s00203-023-03752-0 · Cited by 17
Liang, S., Yao, Z., Chen, J., Jin, Q. Y., Dai, Y., & Li, H. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.123022 · Cited by 23
Jin, W., Cho, S., Laxi, N., Bao, T., Dai, L., Yu, H., Qi, R., Zhang, J., Ba, G., & Fu, M. (2022) · Molecules · doi:10.3390/molecules27103148 · Cited by 16
Alonso‐Peña, M., Barrio, M. D., Peleteiro‐Vigil, A., Jiménez-González, C., Santos‐Laso, Á., Arias, M., Iruzubieta, P., & Crespo, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310718 · Cited by 19
Yi, M., Fasina, O. B., Li, Y., Xiang, L., & Qi, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316684 · Cited by 17
Altered lipid metabolism and the development of metabolic-associated fatty liver disease
Foster, C., Gagnon, C. A., & Ashraf, A. P. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000933 · Cited by 19
A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD
Li, Z., Gong, R., Chu, H., Zeng, J., Chen, C., Xu, S., Hu, L., Gao, W., Li, Z., Yuan, H., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117526 · Cited by 16
The footprint of gut microbiota in gallbladder cancer: a mechanistic review
Liu, S., Li, W., Chen, J., Li, M., Geng, Y., Liu, Y., & Wu, W. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1374238 · Cited by 18
Singh, S., Kriti, M., Catanzaro, R., Marotta, F., Malvi, M., Jain, A. K., Verma, V., Nagpal, R., Tiwari, R. R., & Kumar, M. (2024) · Livers · doi:10.3390/livers4030032 · Cited by 17
Hoffmann, C., Gerber, P. A., Cavelti‐Weder, C., Licht, L., Kotb, R. E., Dweik, R. A., Cherfane, M., Bornstein, S. R., & Perakakis, N. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1834-9008 · Cited by 19
Ganesan, R., & Suk, K. T. (2022) · Livers · doi:10.3390/livers2030012 · Cited by 16
Al-Najjar, Y. A., Arabi, M., Paul, P., & Châari, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1052619 · Cited by 18
He, L., Bao, T., Yang, Y., Wang, H., Gu, C., Chen, J., Zhai, T., He, X., Wu, M., Zhao, L., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114786 · Cited by 19
Assalin, H. B., Almeida, K. C. G. D., Guadagnini, D., Santos, A., Teixeira, C. J., Bordin, S. A., Rocha, G. Z., & Saad, M. J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213766 · Cited by 15
Matsumoto, Y., Fujii, H., Harima, M., Okamura, H., Yukawa‐Muto, Y., Odagiri, N., Motoyama, H., Kotani, K., Kozuka, R., Kawamura, E., et al. (2023) · Nutrients · doi:10.3390/nu15051175 · Cited by 15
Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends
Pezzino, S., Sofia, M., Mazzone, C., Litrico, G., Agosta, M., Greca, G. L., & Latteri, S. (2024) · Scientific Reports · doi:10.1038/s41598-023-50190-5 · Cited by 16
Mantri, A., Köhlmoos, A., Schelski, D. S., Seel, W., Stoffel‐Wagner, B., Krawitz, P. M., Stehle, P., Holst, J. J., Weber, B., Koban, L., et al. (2024) · Nutrients · doi:10.3390/nu16091300 · Cited by 17
Li, Q., Dai, W., Kong, J., Tian, Y., & Chen, Y. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00782-w · Cited by 15
Singla, T., Muneshwar, K. N., Pathade, A. G., & Yelne, S. (2023) · Cureus · doi:10.7759/cureus.45884 · Cited by 18
Healthy diet intervention reverses the progression of NASH through gut microbiota modulation
Panyod, S., Wu, W., Hu, M.-Y., Huang, H., Chen, R.-A., Chen, Y., Shen, T. D., Ho, C., Liu, C., Chuang, H.-L., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01868-23 · Cited by 15
Hizo, G. H., & Rampelotto, P. H. (2023) · Microorganisms · doi:10.3390/microorganisms11122999 · Cited by 15
The oral microbial odyssey influencing chronic metabolic disease
Gupta, U., & Dey, P. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2296346 · Cited by 15
Fukumoto, K., Hikita, H., Saito, Y., Makino, Y., Soma, K., Kato, S., Sasaki, Y., Myojin, Y., Sato, K., Sakane, S., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101698 · Cited by 15
Sánchez‐Tapia, M., Tobón‐Cornejo, S., Noriega, L. G., Vázquez-Manjarrez, N., Coutiño-Hernández, D., Granados‐Portillo, O., Román-Calleja, B. M., Ruiz‐Margáin, A., Macías‐Rodríguez, R. U., Tovar, A. R., et al. (2024) · Nutrients · doi:10.3390/nu16162594 · Cited by 14
Rein‐Fischboeck, L., Haberl, E. M., Pohl, R., Feder, S., Liebisch, G., Krautbauer, S., & Buechler, C. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1114-4 · Cited by 15
Gay, M. D., Cao, H., Shivapurkar, N., Dakshanamurthy, S., Kallakury, B., Tucker, R. D., Kwagyan, J., & Smith, J. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031899 · Cited by 14
Li, S., Zhuge, A., Wang, K., Xia, J., Wang, Q., Han, S., Shen, J., & Li, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1081553 · Cited by 14
Alam, N., Jia, L., Cheng, A., Ren, H., Fu, Y., Ding, X., Haq, I. U., & Liu, E. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1390483 · Cited by 14
Mu, Y., Li, J., Kang, J., Eto, H., Zai, K., Kishimura, A., Hyodo, F., Mori, T., & Katayama, Y. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00432 · Cited by 14
Bacil, G. P., Cogliati, B., Cardoso, D. R., Barbisan, L. F., & Romualdo, G. R. (2022) · Food & Function · doi:10.1039/d2fo01488b · Cited by 16
Wang, L., Jiang, Y., Yu, Q., Xiao, C., Sun, J., Weng, L., & Qiu, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1145430 · Cited by 15
Sharma, R., Majee, C., Mazumder, R., Padhi, S., Khan, F., & Pal, R. S. (2024) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.1s.4 · Cited by 15
Schophaus, S., Creasy, K. T., Koop, P., Clusmann, J., Jaeger, J. W., Punnuru, V., Koch, A. H., Trautwein, C., Loomba, R. S., Luedde, T., et al. (2024) · Liver International · doi:10.1111/liv.16055 · Cited by 13
Shu, Y., Lin, H., Jin, Y. E., Yang, L., & Yu, J. I. N. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123095 · Cited by 13
Metadata
- Authors
- Kolodziejczyk, A. A., Zheng, D., Shibolet, O., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Tel Aviv Sourasky Medical Center (IL)
- Corresponding author
- Elinav, Eran
- Venue
- EMBO Molecular Medicine
- Published
- 2018-12-27
- Volume
- 11
- Issue
- 2
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6365925
- OpenAlex
- W2907493655
- Cited by
- 523
- References
- 125
- Citations by year
- 2026: 30 · 2025: 63 · 2024: 73 · 2023: 94 · 2022: 91 · 2021: 76 · 2020: 71 · 2019: 25
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- European Union's Horizon 2020 (747114)
- European Crohn's and Colitis Organization (ECCO) Fellowship
- Ke Lin Program of the First Affiliated Hospital of Sun Yat‐sen University
- Alexander Grass foundation
- Y. and R. Ungar
- Gurwin Family Fund for Scientific Research
- Crown Endowment Fund for Immunological Research
- Else Kroener‐Fresenius Foundation
- Benoziyo Endowment Fund for the Advancement of Science
- Adelis Foundation
- French National Center for Scientific Research
- European Research Council
- Marie Curie Integration grant
- Rising Tide Foundation
- Helmholtz Foundation
- Canadian Institute of Advanced Research
- The Bill & Melinda Gates Foundation & Howard Hughes Medical Institute
- Abisch‐Frenkel Foundation for the Promotion of Life Sciences
- Leona M. and Harry B. Helmsley Charitable Trust
- German–Israeli Foundation for Scientific Research and Development
- Israel Science Foundation
- Minerva Foundation
- European Foundation for the Study of Diabetes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut microbiota, microbiome, cardiometabolic syndrome, obesity, diabetes mellitus, dyslipidemia, hepatic lipid metabolism, hepatic carbohydrate metabolism, inflammation, gut microbiota metabolites, liver cirrhosis, hepatocellular carcinoma
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Disease Progression, Carbohydrate Metabolism, Lipid Metabolism, Microbiota, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.